Results 231 to 240 of about 28,689 (318)

Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628) [PDF]

, 2018
Nikolas von Bubnoff, Gabriele Ihorst, Olga Grishina, Nadine Röthling, Hartmut Bertz, Justus Duyster, Jürgen Finke, Robert Zeiser   +7 more
openalex   +1 more source

Experience of Myeloproliferative Neoplasms Guidelines in the United Kingdom: Perspective and International Context [PDF]

, 2016
Harrison, Claire, McMullin, Mary Frances
core   +1 more source

Xenopax is effective for the treatment and prophylaxis of acute graft-versus-host disease. [PDF]

Blood Sci
Liu D.
europepmc   +1 more source

Ruxolitinib in Myelofibrosis and Polycythemia Vera [PDF]

Journal of the Advanced Practitioner in Oncology, 2016
openaire   +3 more sources

ROCK 2 inhibition with belumosudil for the treatment of chronic graft-versus-host disease: a narrative review. [PDF]

Ther Adv Hematol
Wang X, Liu Y, Chen T, Yao H, Song Q, Zhang X.   +5 more
europepmc   +1 more source

Phase I study of ruxolitinib in previously treated patients with low or intermediate-1 risk myelodysplastic syndrome with evidence of NF-kB activation [PDF]

, 2018
Yasmin Abaza, Juliana E. Hidalgo‐Lόpez, Srđan Verstovšek, Elias Jabbour, Farhad Ravandi, Gautam Borthakur, Zeev Estrov, Yesid Alvarado, Jan A. Burger, Heather Schneider, Kelly A. Soltysiak, Yue Wei, Hagop M. Kantarjian, Carlos E. Bueso‐Ramos, Guillermo Garcia‐Manero   +14 more
openalex   +1 more source

Real-World Use of Topical Ruxolitinib in Vitiligo: Retrospective Cross-Sectional Mixed Methods Infodemiology Study of the r/Vitiligo Subreddit.

J Med Internet Res
Kirchberger MC, Berking C, Eisenried A.
europepmc   +1 more source

Melanoma during Ruxolitinib Treatment for Myelofibrosis. [PDF]

Acta Derm Venereol
Zhong L, Li H, Wen G.
europepmc   +1 more source

Myelofibrosis patients can develop extramedullary complications including renal amyloidosis and sclerosing hematopoietic tumor while otherwise meeting traditional measures of ruxolitinib response [PDF]

, 2018
Daria V. Babushok, Ernest Nelson, Jennifer J.D. Morrissette, Shivam Joshi, Matthew B. Palmer, Dale Frank, Carolyn L. Cambor, Elizabeth O. Hexner   +7 more
openalex   +1 more source

Autonomous artificial intelligence prescribing a drug to prevent severe acute graft-versus-host disease in HLA-haploidentical transplants. [PDF]

Nat Commun
Chen J, Cao Y, Feng Y, Qi S, Yang D, Hu Y, Pang A, Shen Q, Luo J, Gong X, Zhang R, Zhai X, Li X, Yan W, Zhang X, Chen M, Niu M, Wei J, Liang C, Zhai W, Zhao N, Liu X, Liu S, Zhai W, Li R, Shao X, Zhang D, Wang M, Pan P, Xu M, Zhang W, Xu Y, Zhu X, Guo Y, Wang H, Song Z, Gale RP, Han M, Feng S, Jiang E.   +39 more
europepmc   +1 more source